A study published in the Journal of Clinical Anesthesia investigated the relationship between semaglutide use and residual gastric content in patients undergoing upper gastrointestinal endoscopy (EGD). Conducted by researchers at the D’Or Institute for Research and Education (IDOR), the retrospective study analyzed medical records of 404 patients to assess the risks associated with semaglutide use, a glucagon-like peptide-1 (GLP-1) receptor agonist, in anesthetic procedures. The findings highlight the importance of revisiting preoperative fasting guidelines for patients on GLP-1 analogs to ensure the safety and efficacy of endoscopic procedures. GLP-1 analogs Read More